The strict customs scrutiny and non-clearance of imports from China has now hit the pharmaceutical sector -- the lifeline amid the pandemic -- making industry representatives to reach out to the government and seek urgent clearance of the goods at ports and airports.
The letter was also marked to the PMO and the Directorate General of Foreign Trade among others. “Very critical KSM’s (Key Starting Material), intermediates & API’s (Active Pharmaceutical Ingredients) are not being cleared for the reasons not known to the industry at all,” said the letter by Dinesh Dua, Chairman, Pharmexcil. Even critical devices such as ‘infrared thermometers’ and ‘pulse oximeters’ which are specifically aimed at COVID-19 diagnosis as also ‘glucometers’ and ‘strips’ are also held up at the Delhi airport, he said. The self reliance or the “Aatmanirbhar” principle will take its own time in a phased and considered manner through the Centre’s incentives such as ‘pharma parks’ as also production linked incentives’ (PLI).